ArticleFrontiers in psychiatry2025
Sleep quality mediates the association between tea consumption and duration of COVID-19-related symptoms in middle-aged and elderly adults (aged 50 and above).
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The association between tea consumption and the duration of COVID-19-related symptoms remains inconclusive. This cross-sectional study investigates the potential mediating role of sleep quality in this association. The association between tea consumption and the duration of COVID-19-related symptoms remains inconclusive. This cross-sectional study aims to investigate the potential mediating role of sleep quality in this association. Methods: We conducted a cross-sectional study using data from middle-aged and elderly adults (aged 50 and above) in Weitang Town in 2023. Detailed information on tea consumption, duration of COVID-19-related symptoms, and sleep quality was collected through face-to-face interviews using pre-designed questionnaires. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), which evaluated sleep quality over the past month during the acute phase of COVID-19. Spearman correlation analysis was employed to examine the relationships between variables. mediation analysis utilized a mediation model with multi-category independent variables. Results: Tea consumption was negatively associated with sleep quality, which in turn was positively associated with COVID-19 symptom duration. Mediation analysis showed sleep quality partially mediated the relationship between daily tea drinking and symptom duration, and fully mediated associations between green tea consumption, tea drinking for <15 or ≥30 years, tea concentration, and symptom duration. The mediation effect accounted for 11%-21% of the total effect. Conclusions: Tea consumption is associated with shorter duration of COVID-19-related symptoms, with sleep quality acting as a mediator. These findings highlight the potential of improving sleep quality to reduce symptom duration, but conclusions are limited by the cross-sectional design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.